150 related articles for article (PubMed ID: 37386491)
1. Does the implementation of an incentive scheme increase adherence to diabetes guidelines? A retrospective cohort study of managed care enrollees.
Farcher R; Graber SM; Thüring N; Blozik E; Huber CA
BMC Health Serv Res; 2023 Jun; 23(1):707. PubMed ID: 37386491
[TBL] [Abstract][Full Text] [Related]
2. Antihyperlipidemic Medication Treatment Patterns and Statin Adherence Among Patients with ASCVD in a Managed Care Plan After Release of the 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol.
Bellows BK; Olsen CJ; Voelker J; Wander C
J Manag Care Spec Pharm; 2016 Aug; 22(8):892-900. PubMed ID: 27459651
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the relationship between a chronic disease care management program and california pay-for-performance diabetes care cholesterol measures in one medical group.
Cutler TW; Palmieri J; Khalsa M; Stebbins M
J Manag Care Pharm; 2007 Sep; 13(7):578-88. PubMed ID: 17874864
[TBL] [Abstract][Full Text] [Related]
4. The effect of financial incentives on the quality of health care provided by primary care physicians.
Scott A; Sivey P; Ait Ouakrim D; Willenberg L; Naccarella L; Furler J; Young D
Cochrane Database Syst Rev; 2011 Sep; (9):CD008451. PubMed ID: 21901722
[TBL] [Abstract][Full Text] [Related]
5. The association of clinical guideline adherence and pay-for-performance among patients with diabetes.
Lai CL; Hou YH
J Chin Med Assoc; 2013 Feb; 76(2):102-7. PubMed ID: 23351421
[TBL] [Abstract][Full Text] [Related]
6. Short-run associations between medical care expenditures and adherence to clinical practice guideline-based measures for diabetes.
Ozminkowski RJ; Wang S; Marder WD; Azzolini J
Value Health; 2000; 3 Suppl 1():29-38. PubMed ID: 16464207
[TBL] [Abstract][Full Text] [Related]
7. Measuring diabetes guideline adherence with claims data: systematic construction of indicators and related challenges.
Ulyte A; Bähler C; Schwenkglenks M; von Wyl V; Gruebner O; Wei W; Blozik E; Brüngger B; Dressel H
BMJ Open; 2019 Apr; 9(4):e027138. PubMed ID: 31023761
[TBL] [Abstract][Full Text] [Related]
8. Exploring geographic variation of and influencing factors for utilization of four diabetes management measures in Swiss population using claims data.
Wei W; Gruebner O; von Wyl V; Dressel H; Ulyte A; Brüngger B; Blozik E; Bähler C; Braun J; Schwenkglenks M
BMJ Open Diabetes Res Care; 2020 Feb; 8(1):. PubMed ID: 32094222
[TBL] [Abstract][Full Text] [Related]
9. Quality of care provided to patients with diabetes mellitus in Puerto Rico; managed care versus fee-for-service experience.
Rodríguez-Vigil E; Kianes-Pérez Z
Endocr Pract; 2005; 11(6):376-81. PubMed ID: 16718949
[TBL] [Abstract][Full Text] [Related]
10. Descriptive analysis of mail interventions with physicians and patients to improve adherence with antihypertensive and antidiabetic medications in a mixed-model managed care organization of commercial and Medicare members.
Jing S; Naliboff A; Kaufman MB; Choy M
J Manag Care Pharm; 2011 Jun; 17(5):355-66. PubMed ID: 21657805
[TBL] [Abstract][Full Text] [Related]
11. Performance-based financial incentives for diabetes care: an effective strategy?
Latham LP; Marshall EG
Can J Diabetes; 2015 Feb; 39(1):83-7. PubMed ID: 25444683
[TBL] [Abstract][Full Text] [Related]
12. Effects of paying physicians based on their relative performance for quality.
Young GJ; Meterko M; Beckman H; Baker E; White B; Sautter KM; Greene R; Curtin K; Bokhour BG; Berlowitz D; Burgess JF
J Gen Intern Med; 2007 Jun; 22(6):872-6. PubMed ID: 17443360
[TBL] [Abstract][Full Text] [Related]
13. Provider attitudes associated with adherence to evidence-based clinical guidelines in a managed care setting.
Waddimba AC; Meterko M; Beckman HB; Young GJ; Burgess JF
Med Care Res Rev; 2010 Feb; 67(1):93-116. PubMed ID: 19692552
[TBL] [Abstract][Full Text] [Related]
14. Factors hindering the adherence to clinical practice guideline for diabetes mellitus in the Palestinian primary healthcare clinics: a qualitative study.
Radwan M; Akbari Sari A; Rashidian A; Takian A; Elsous A; Abou-Dagga S
BMJ Open; 2018 Sep; 8(9):e021195. PubMed ID: 30185569
[TBL] [Abstract][Full Text] [Related]
15. A set of four simple performance measures reflecting adherence to guidelines predicts hospitalization: a claims-based cohort study of patients with diabetes.
Huber CA; Brändle M; Rapold R; Reich O; Rosemann T
Patient Prefer Adherence; 2016; 10():223-31. PubMed ID: 27042016
[TBL] [Abstract][Full Text] [Related]
16. Impact of adherence and weight loss on glycemic control in patients with type 2 diabetes: cohort analyses of integrated medical record, pharmacy claims, and patient-reported data.
McAdam-Marx C; Bellows BK; Unni S; Wygant G; Mukherjee J; Ye X; Brixner DI
J Manag Care Spec Pharm; 2014 Jul; 20(7):691-700. PubMed ID: 24967522
[TBL] [Abstract][Full Text] [Related]
17. Integrating pay for performance with educational strategies to improve diabetes care.
Foels T; Hewner S
Popul Health Manag; 2009 Jun; 12(3):121-9. PubMed ID: 19534576
[TBL] [Abstract][Full Text] [Related]
18. Effects of Changes in Diabetes Pay-for-Performance Incentive Designs on Patient Risk Selection.
Hsieh HM; Tsai SL; Mau LW; Chiu HC
Health Serv Res; 2016 Apr; 51(2):667-86. PubMed ID: 26152649
[TBL] [Abstract][Full Text] [Related]
19. Effects of individual and neighborhood social risks on diabetes pay-for-performance program under a single-payer health system.
Tsai WC; Huang KH; Chen PC; Chang YC; Chen MS; Lee CB
Soc Sci Med; 2023 Jun; 326():115930. PubMed ID: 37146356
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
